Status:
COMPLETED
Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Non-small Cell Lung Cancer (NSCLC)
Eligibility:
All Genders
18+ years
Brief Summary
We are collecting clinical notes and results of imaging studies (CT and PET scans) from referring physicians who follow the clinical status of patients treated with radiofrequency ablation (RFA). The ...
Detailed Description
Radiofrequency ablation (RFA) is a relatively new treatment for localized forms of cancer. It requires that a device called a needle-electrode be placed in the tumor. Radiofrequency energy can be pass...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with lung masses
- Patients who consent to radiofrequency ablation of mass
Exclusion
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00641238
Start Date
March 1 2004
End Date
February 1 2011
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Upstate Medical University
Syracuse, New York, United States, 13201